VI

VIVOZON PHARMACEUTICAL CO., LTD.

Develops multi-target drugs for pain and central nervous system (CNS) diseases.

082800 | KO

Overview

Corporate Details

ISIN(s):
KR7082800004
LEI:
Country:
South Korea
Address:
경기도 화성시 향남읍 제약공단2길 34-40, 화성시

Description

VIVOZON PHARMACEUTICAL CO., LTD. is a research and development company specializing in the discovery and commercialization of innovative drugs, with a primary focus on pain and central nervous system (CNS) diseases. The company utilizes a multi-target drug development platform to create new chemical entities that act on multiple targets to achieve synergistic efficacy. This approach integrates efficacy-based screening from the early stages of discovery to identify candidate substances with a high potential for successful clinical development. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic for post-operative pain management. The company is actively expanding its pipeline to address a broader range of unmet medical needs within the CNS field.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-21 00:00
주요사항보고서(자기주식처분결정)
Korean 28.8 KB
2025-03-20 00:00
주식등의대량보유상황보고서(일반)
Korean 114.7 KB
2025-03-20 00:00
감사보고서제출
Korean 25.3 KB
2025-03-20 00:00
사업보고서 (2024.12)
Korean 627.2 KB
2025-03-18 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-03-13 00:00
주주총회소집결의
Korean 7.2 KB
2025-03-13 00:00
주주총회집중일개최사유신고
Korean 4.6 KB
2025-03-13 00:00
주주총회소집공고
Korean 203.7 KB
2025-02-21 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.3 KB
2025-02-14 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-02-14 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-02-12 00:00
임원ㆍ주요주주특정증권등거래계획보고서
Korean 48.2 KB
2025-02-11 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-01-15 00:00
주식등의대량보유상황보고서(일반)
Korean 94.6 KB
2024-12-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.8 KB

Automate Your Workflow. Get a real-time feed of all VIVOZON PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for VIVOZON PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for VIVOZON PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.